01
What your consultation covers
Goals, prior weight-management efforts, medication history, cardiometabolic risk, sleep, eating patterns and related symptoms are reviewed. Treatment may involve regular follow-up and monitoring.
02
Medication options
FDA-approved medicines, including appropriate GLP-1- or GIP-based therapies, may be discussed for patients who meet the labeled criteria. Availability, product status, insurance coverage and prescribing decisions vary; compounded products are not interchangeable with FDA-approved versions.
03
Safety and realistic expectations
Potential adverse effects and medical precautions are discussed before prescribing. Results differ, and long-term management often requires changes in both treatment and habits.